ENGYSTOL tablett Estônia - estoniano - Ravimiamet

engystol tablett

biologische heilmittel heel gmbh - homöopaatilised preparaadid - tablett - 250tk; 50tk

ALPHA D3-TEVA pehmekapsel Estônia - estoniano - Ravimiamet

alpha d3-teva pehmekapsel

teva pharma b.v. - alfakaltsidool - pehmekapsel - 0,25mcg 30tk

BRONKEEL tablett Estônia - estoniano - Ravimiamet

bronkeel tablett

biologische heilmittel heel gmbh - homöopaatilised preparaadid - tablett - 50tk

HEPEEL tablett Estônia - estoniano - Ravimiamet

hepeel tablett

biologische heilmittel heel gmbh - homöopaatilised preparaadid - tablett - 250tk; 50tk

NERHEEL tablett Estônia - estoniano - Ravimiamet

nerheel tablett

biologische heilmittel heel gmbh - homöopaatilised preparaadid - tablett - 50tk

TRAUMEEL S salv Estônia - estoniano - Ravimiamet

traumeel s salv

biologische heilmittel heel gmbh - homöopaatilised preparaadid - salv - 50g 1tk

TRAUMEEL S tablett Estônia - estoniano - Ravimiamet

traumeel s tablett

biologische heilmittel heel gmbh - homöopaatilised preparaadid - tablett - 250tk; 50tk

NASOFAN ninasprei, suspensioon Estônia - estoniano - Ravimiamet

nasofan ninasprei, suspensioon

teva pharma b.v. - flutikasoon - ninasprei, suspensioon - 0,05mg 1annus 360annus 1tk

ALPHA D3-TEVA pehmekapsel Estônia - estoniano - Ravimiamet

alpha d3-teva pehmekapsel

teva pharma b.v. - alfakaltsidool - pehmekapsel - 1mcg 10tk

Budesonide/Formoterol Teva Pharma B.V. União Europeia - estoniano - EMA (European Medicines Agency)

budesonide/formoterol teva pharma b.v.

teva pharma b.v. - budesonide, formoterol - astma - ravimid hingamisteede obstruktiivsete haiguste, - budesonide / formoterol teva pharma b. on näidustatud ainult 18-aastastel ja vanematel täiskasvanutel. asthmabudesonide/formoterol teva pharma b. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.